Nature Communications (Jun 2022)
Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates
- Nawal Al Kaabi,
- Abderrahim Oulhaj,
- Subhashini Ganesan,
- Farida Ismail Al Hosani,
- Omer Najim,
- Halah Ibrahim,
- Juan Acuna,
- Ahmed R. Alsuwaidi,
- Ashraf M. Kamour,
- Ashraf Alzaabi,
- Badreyya Ahmed Al Shehhi,
- Habiba Al Safar,
- Salah Eldin Hussein,
- Jehad Saleh Abdalla,
- Dalal Saeed Naser Al Mansoori,
- Ahmed Abdul Kareem Al Hammadi,
- Mohammed A. Amari,
- Ahmed Khamis Al Romaithi,
- Stefan Weber,
- Santosh Elavalli,
- Islam Eltantawy,
- Noura Khamis Alghaithi,
- Jumana Nafiz Al Azazi,
- Stephen Geoffrey Holt,
- Mohamed Mostafa,
- Rabih Halwani,
- Hanif Khalak,
- Wael Elamin,
- Rami Beiram,
- Walid Zaher
Affiliations
- Nawal Al Kaabi
- Sheikh Khalifa Medical City SEHA
- Abderrahim Oulhaj
- College of Medicine and Health Sciences, Khalifa University
- Subhashini Ganesan
- G42 Healthcare, Masdar City
- Farida Ismail Al Hosani
- Abu Dhabi Public Health Center – ADPHC
- Omer Najim
- Department of Health (DOH)
- Halah Ibrahim
- College of Medicine and Health Sciences, Khalifa University
- Juan Acuna
- College of Medicine and Health Sciences, Khalifa University
- Ahmed R. Alsuwaidi
- College of Medicine and Health Sciences, United Arab Emirates University
- Ashraf M. Kamour
- Sheikh Khalifa Medical City SEHA
- Ashraf Alzaabi
- College of Medicine and Health Sciences, United Arab Emirates University
- Badreyya Ahmed Al Shehhi
- Abu Dhabi Public Health Center – ADPHC
- Habiba Al Safar
- Khalifa University of Science and Technology
- Salah Eldin Hussein
- Sheikh Khalifa Medical City SEHA
- Jehad Saleh Abdalla
- Sheikh Khalifa Medical City SEHA
- Dalal Saeed Naser Al Mansoori
- Tawam hospital SEHA
- Ahmed Abdul Kareem Al Hammadi
- Tawam hospital SEHA
- Mohammed A. Amari
- Sheikh Khalifa Medical City SEHA
- Ahmed Khamis Al Romaithi
- Sheikh Khalifa Medical City SEHA
- Stefan Weber
- Reference Laboratory for Infectious Diseases (RLID) and Union 71
- Santosh Elavalli
- G42 Healthcare, Masdar City
- Islam Eltantawy
- IROS (Insights Research Organization & Solutions)
- Noura Khamis Alghaithi
- Ambulatory Health Services- SEHA
- Jumana Nafiz Al Azazi
- Abu Dhabi Health Services Company- SEHA
- Stephen Geoffrey Holt
- SEHA Kidney Care, SEHA, Abu Dhabi Health Services Company
- Mohamed Mostafa
- PDC -CRO, Clinical research organization
- Rabih Halwani
- College of Medicine, University of Sharjah
- Hanif Khalak
- G42 Healthcare, Masdar City
- Wael Elamin
- G42 Healthcare, Masdar City
- Rami Beiram
- College of Medicine and Health Sciences, United Arab Emirates University
- Walid Zaher
- College of Medicine and Health Sciences, Khalifa University
- DOI
- https://doi.org/10.1038/s41467-022-30835-1
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 9
Abstract
There is limited real-world evidence for the effectiveness of the BBIBP-CorV (Sinopharm) vaccine against severe COVID-19 disease. Here, the authors use data from Abu Dhabi and estimate effectiveness at 80% against hospitalization; 86% against critical care admission and 84% against death.
